Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225628 · ClinicalTrials.gov registry record · NA
Improving Quality With Outpatient Decision Support
A NA study of Hypertension and Coronary Artery Disease, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 1
- Study location
NCT00225628: Completed NA study of Hypertension and Coronary Artery Disease, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT00225628 is a NA study of Hypertension and Coronary Artery Disease that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 3,000 participants, below the 3,501-participant average among 470 other Hypertension trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00225628, a NA study of Hypertension and Coronary Artery Disease, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Assesses physician compliance with paper-based and electronic guidelines, reminders, and alerts for outpatient settings. Target areas for the reminders and alerts are disease management, medication management, and interpretation of abnormal test results.
Conditions Studied
Interventions
- BEHAVIORAL Computerized Reminders Medications Monitoring
- BEHAVIORAL Computerized Test Results Management Application
- BEHAVIORAL Computerized Reminders Hypertension Management
- BEHAVIORAL Computerized Reminders Osteoporosis Screening and Mgt
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2000-09 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00225628 record still lists
NCT00225628 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,501-participant average among 470 other Hypertension trials with a reported enrollment target (14% lower).
The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 4 interventions - of which Computerized Reminders Medications Monitoring is the first listed.
NCT00225628 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00225628 about?
NCT00225628 is a clinical study titled "Improving Quality With Outpatient Decision Support". Assesses physician compliance with paper-based and electronic guidelines, reminders, and alerts for outpatient settings. Target areas for the reminders and alerts are disease management, medication management, and interpretation of abnormal test results.
What is the current status of trial NCT00225628?
This trial is currently completed. It is a NA study. The enrollment target is 3,000 participants. The study started on 2000-09. Estimated completion is 2006-12.
What conditions does trial NCT00225628 study?
This clinical trial studies the following conditions: Hypertension, Coronary Artery Disease, Diabetes Mellitus, Osteoporosis, Hyperlipidemia.
What interventions are being tested in trial NCT00225628?
The interventions under investigation include: Computerized Reminders Medications Monitoring (BEHAVIORAL), Computerized Test Results Management Application (BEHAVIORAL), Computerized Reminders Hypertension Management (BEHAVIORAL), Computerized Reminders Osteoporosis Screening and Mgt (BEHAVIORAL).
Who is sponsoring clinical trial NCT00225628?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00225628 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00225628's enrollment target sits among peer trials
3,000 35th of 470 higher than 436 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia